Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Auto Casualty
Article
WorkCompWire: 5 Things You Should Know about IMEs and COVID-19
Though the COVID-19 pandemic has presented many challenges, workers’ compensation (WC) programs have continued to push claims forward – often with
Mitchell
Article
Workers’ Comp Data: About 25% of COVID-19 Claims Have Associated Medical Costs
Data analysis by Aarthi Thiruvengadam. In 2020, the workers’ compensation industry endured many changes due to the COVID-19 pandemic, incl
Mitchell
News Release
Mitchell’s Q1 Industry Trends Report Examines the Ongoing Effects of COVID-19 and Implications for Property & Casualty Claims and Collision Repair
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the Property &
Mitchell
Article
Average Length of Rental for Repairable Vehicles: Q4 2020
The quarterly LOR summary is produced by
Mitchell
Article
The Evolution of Claims Automation
COVID-19 has hastened the pace of digital transformation in many industries, including auto insurance.
Mitchell
Article
Current Used Vehicle Market Conditions: Q4 2020
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.